Sterno‐costo‐clavicular Hyperostosis

Taylor, H G; Dawes, P. T.

doi:10.1111/j.1742-1241.1992.tb10368.x

Int J Clinical Practice

1992

DOI: 10.1111/j.1742-1241.1992.tb10368.x

|View full text |Cite

Sterno‐costo‐clavicular Hyperostosis

H G Taylor¹,

P. T. Dawes²

Abstract: SUMMARYSterno‐costo‐clavicular hyperostosis (SCCH) is a condition of unknown aetiology in which a chronic inflammatory osteitis affects predominantly the medial clavicle, sternum and distal tibia and femur, sometimes associated with skin disease. We report on two patients with the typical bony lesions of SCCH and no associated skin disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2001

2016

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 7 publications

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Diagnostic delay in sternocostoclavicular hyperostosis: Impact on various aspects of quality of life

Kloot¹,

Chotkan²,

Kaptein³

et al. 2010

Arthritis Care & Research

View full text Add to dashboard Cite

Objective. Sternocostoclavicular hyperostosis (SCCH) is a rare, debilitating, chronic inflammatory disorder of the anterior chest wall due to a chronic sterile osteomyelitis of unknown origin, often associated with characteristic skin lesions of palms and soles: pustulosis palmoplantaris. SCCH goes often unrecognized for years before the diagnosis is established and treatment instituted. The objective of this study was to trace the diagnostic paths of patients with SCCH and to investigate the consequences associated with diagnostic delay. Methods. Data were collected through structured interviews of 52 patients with a clinically, scintigraphically, and radiologically established diagnosis of SCCH. Results. The majority of patients presented with swelling and/or pain in the sternocostoclavicular region and/or limited movement of the shoulder girdle. Pustulosis palmoplantaris was present in ϳ30% of patients. The disease went unrecognized for a median of 3.5 years. Patients were often seen by at least 3 members of the medical profession before the diagnosis was suspected and eventually established. Lack of recognition of the clinical manifestations of the disease and delay in diagnosis were associated with important physical, psychological, and socioeconomic consequences affecting quality of life. Conclusion. SCCH remains an ill-recognized disease despite its characteristic clinical features. A low level of awareness of the disorder leads to a delay in diagnosis, which has a significant impact on various aspects of quality of life. Awareness should be raised for this disorder, enabling timely diagnosis and initiation of treatment to prevent the irreversible physical and psychological sequelae associated with the protracted untreated state.

show abstract

Diagnostic delay in sternocostoclavicular hyperostosis: Impact on various aspects of quality of life

Kloot¹,

Chotkan²,

Kaptein³

et al. 2010

Arthritis Care & Research

View full text Add to dashboard Cite

show abstract

SAPHO syndrome: A review

Rukavina

2015

Journal of Children's Orthopaedics

175

167

View full text Add to dashboard Cite

IntroductionSynovitis–acne–pustulosis–hyperostosis–osteitis (SAPHO) is an acronym for various osteoarticular and dermatological manifestations that can appear in the same patient. It is a rare syndrome, but since its awareness has increased, there have been more and more such reports in the literature.AimsThe objectives of this review are to summarize the current state of knowledge on pediatric and adult-onset SAPHO syndrome, and to discuss treatment strategies that should be considered.ResultsThe SAPHO syndrome can affect patients of any age, and its etiology is still not known. The syndrome has its cognizable radiological characteristics that are most important in making the diagnosis. There are several diagnostic criteria as well, but they need further validation. No standard treatment protocols are available and current treatment options are not evidenced-based due to the rarity of the syndrome. Therapy is empirical and aimed at easing pain and modifying the inflammatory process. It includes nonsteroidal anti-inflammatory drugs (NSAIDs) as the first-line agents. Antibiotics, corticosteroids, disease-modifying anti-rheumatic drugs, biologicals targeting tumor necrosis factor alpha or interleukin-1, and bisphosphonates have all been used with variable success. Surgery is reserved to treat complications. Even though it is a disease with good long-term prognosis, its treatment remains a challenge and the results are known to be disappointing, especially with the skin component of the disease.ConclusionIt is expected that these patients present at the time of diagnosis and the treatment should be as early, effective, and safe as possible in order to prevent osteoarticular progression and to limit the adverse events associated with pharmacological drugs.

show abstract

Atraumatic conditions of the sternoclavicular joint

Hiramuro-Shoji¹,

Wirth²,

Rockwood³

2003

Journal of Shoulder and Elbow Surgery

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Sterno‐costo‐clavicular Hyperostosis

Cited by 7 publications

References 8 publications

Diagnostic delay in sternocostoclavicular hyperostosis: Impact on various aspects of quality of life

Diagnostic delay in sternocostoclavicular hyperostosis: Impact on various aspects of quality of life

SAPHO syndrome: A review

Atraumatic conditions of the sternoclavicular joint

Contact Info

Product

Resources

About